A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: A Kansai Clinical Oncology Group study (KCOG0015 trial)

► Dose-dense weekly paclitaxel and carboplatin is feasible in endometrial cancer. ► This regimen is effective in any setting of salvage, neo-adjuvant or adjuvant.